In Vitro Costimulation in HIV and HCV Patients
Author Information
Author(s): Stefanie Kuerten, Tobias R. Schlingmann, Tarvo Rajasalu, Doychin N. Angelov, Paul V. Lehmann, Magdalena Tary-Lehmann
Primary Institution: Institut für Anatomie I, Medizinische Fakultät der Universität zu Köln; Department of Pathology, Case Western Reserve University
Hypothesis
Can in vitro costimulation improve T cell responses in HIV and HCV patients?
Conclusion
The study found that in vitro costimulation did not significantly enhance T cell responses in HIV or HCV patients and caused false-positive results in healthy individuals.
Supporting Evidence
- None of the costimulatory molecules significantly increased T cell responses in HIV patients.
- In HCV patients, only one antigen showed a significant response increase with costimulation.
- All costimulatory methods caused false-positive responses in healthy individuals.
Takeaway
The study tested if adding special signals could help immune cells respond better in patients with HIV and HCV, but it didn't work and even caused confusion in healthy people.
Methodology
The study compared T cell responses in 10 HIV patients, 10 HCV patients, and 6 healthy individuals using ELISPOT assays with various costimulatory agents.
Potential Biases
Potential bias due to the small sample size and the specific patient populations studied.
Limitations
The study did not explore the long-term effects of costimulation or the underlying mechanisms of T cell dysfunction in chronic infections.
Participant Demographics
10 HIV patients, 10 HCV patients, and 6 healthy individuals, with a mix of genders and ages.
Statistical Information
P-Value
P = .02 for NS3 response in HCV patients with IL-7/IL-15
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website